Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer

Emerging combinations of immune checkpoint inhibitors with targeted agents in ovarian and endometrial carcinomas

Date

21 Nov 2020

Session

ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer

Topics

Cytotoxic Therapy;  Targeted Therapy;  Immunotherapy

Tumour Site

Ovarian Cancer

Presenters

Antonio Jose Gonzalez Martin

Authors

A.J. Gonzalez Martin

Author affiliations

  • Medical Oncology Department, Clinica Universidad de Navarra, 28027 - Madrid/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.